Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.38p
   
  • Change Today:
    -0.025p
  • 52 Week High: 9.50
  • 52 Week Low: 1.45
  • Currency: UK Pounds
  • Shares Issued: 543.14m
  • Volume: 11,549,347
  • Market Cap: £12.90m
  • RiskGrade: 747
  • Beta: 1.17

Genedrive Overview

Genedrive is in the health care sector and is currently trading at 2.38p per share. In the last year Genedrive 's share price has ranged from 1.45p to 9.50p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -9498.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 237.0 n/a
Pr/Book 6.4  
Latest F'cast
Revenue 12.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Genedrive Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 2.36 (4.52) (13.87)p n/a n/a n/a n/a 0.0%
30-Jun-20 1.06 (20.38) (54.48)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.69 (1.85) (1.19)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.05 (5.63) 5.50p 3.2 n/a n/a n/a 0.0%
30-Jun-23 0.06 (5.98) (5.50)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Genedrive Company Announcements

NIHR and OLS Funding Package 21-Nov-2024 11:06 RNS
Scottish Health Technology Group publications 04-Nov-2024 13:29 RNS
Director Declaration 21-Oct-2024 15:22 RNS

Genedrive ShareCast News

Director dealings: Genedrive chairman snaps up s... 15-Aug-2024 ShareCast
Genedrive makes first commercial sales of CYP2C1... 12-Aug-2024 ShareCast
Genedrive test ordered by five Manchester area h... 24-May-2024 ShareCast

Latest Genedrive Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Genedrive Market Data

Currency UK Pounds
Share Price 2.38p
Change Today -0.025p
% Change -1.04 %
52 Week High 9.50
52 Week Low 1.45
Volume 11,549,347
Shares Issued 543.14m
Market Cap £12.90m
Beta 1.17
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.94% below the market average50.94% below the market average50.94% below the market average50.94% below the market average50.94% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Trend
37.11% below the market average37.11% below the market average37.11% below the market average37.11% below the market average37.11% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average
Income Not Available
Growth
42.21% below the market average42.21% below the market average42.21% below the market average42.21% below the market average42.21% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Genedrive Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
12:23 20,000 @ 2.48p
12:23 193,045 @ 2.48p
12:23 9,314 @ 2.42p
12:22 46,366 @ 2.49p
12:21 75,000 @ 2.49p

Genedrive Key Personnel

CFO Russell Shaw
CEO Gino Miele

Top of Page